HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, in opposition to the FDA staff review, which had recommended against listing
Goop this is not, at least not in its aesthetic, though a comparison is apt
The peptide binds to actin monomers and influences polymerization dynamics, affecting cytoskeletal organization crucial for cell migration, division, and structural adaptation
Knowing Who Genuinely Benefits A boost culture has grown up around these injections, but the treatment exists to correct a real shortfall
The animal data is consistent and often impressive
What Patients Should Know